1 |
Nowacka-Cieciura E, Karakulska-Prystupiuk E, Żuk-Wasek A, et al. Pure red cell aplasia related to parvovirus B19 infection in simultaneous pancreas and kidney recipient: A case report[J]. Transplant Proc, 2020, 52(8): 2539-2543.
|
2 |
Labbadia F, Salido-Fierréz E, Majado-Martinez J, et al. Pure red cell aplasia in a simultaneous pancreas-kidney transplantation patient: inside the erythroblast[J]. Hematol Rep, 2012, 4(3): e17.
|
3 |
Sharma N, Bajwa R. Parvovirus infection-related anemia after kidney transplantation[J]. Case Rep Transplant, 2020, 2020: 6437392.
|
4 |
Knysak M, Napora M, Misiukiewicz-Poć M, et al. Pure red cell aplasia and antibody-mediated rejection: double trouble in 1 kidney transplant recipient solved by intravenous immunoglobulin infusion: A case report[J]. Transplant Proc, 2020, 52(8): 2530-2532.
|
5 |
Hai An HP, Diem HT, Cuong NT. Parvovirus B19-associated anemia in kidney transplant recipients: A single-center experience[J]. Transplant Proc, 2019, 51(8): 2693-2696.
|
6 |
Baek CH, Kim H, Yang WS, et al. Risk factors and long-term outcomes of parvovirus B19 infection in kidney transplant patients[J]. Transpl Infect Dis, 2017, 19(5): e12754.
|
7 |
Tsinalis D, Dickenmann M, Brunner F, et al. Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin[J]. Am J Kidney Dis, 2002, 40(3): 667-670.
|
8 |
Oramas DM, Setty S, Yeldandi V, et al. A case report of parvovirus B19 infection in a renal allograft[J]. Int J Surg Pathol, 2017, 25(7): 648-651.
|
9 |
Pinto V, Grandy J, Zambrano P, et al. Severe anemia from parvovirus b19 infection in pediatric renal transplant recipients: two case reports[J]. Transplant Proc, 2008, 40(9): 3261-3264.
|
10 |
Becker MR, Schneider B, Reber U, et al. Renal anemia aggravated by long-term parvovirus B19 and cytomegalovirus infection in a renal transplant patient: case report and evaluation of B19 seroprevalence in dialysis patients[J]. Transplant Proc, 2005, 37(10): 4306-4308.
|
11 |
Lui SL, Luk WK, Cheung CY, et al. Nosocomial outbreak of parvovirus B19 infection in a renal transplant unit[J]. Transplantation, 2001, 71(1): 59-64.
|
12 |
Marchand S, Tchernia G, Hiesse C, et al. Human parvovirus B19 infection in organ transplant recipients[J]. Clin Transplant, 1999, 13(1 Pt 1): 17-24.
|
13 |
Keung YK, Chuahirun T, Wesson D. Concomitant parvovirus B19 and cytomegalovirus infections after living-related renal transplantation[J]. Nephrol Dial Transplant, 1999, 14(2): 469-471.
|
14 |
Moudgil A, Shidban H, Nast CC, et al. Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin[J]. Transplantation, 1997, 64(12): 1847-1850.
|
15 |
Sturm I, Watschinger B, Geissler K, et al. Chronic parvovirus B19 infection-associated pure red cell anaemia in a kidney transplant recipient[J]. Nephrol Dial Transplant, 1996, 11(7): 1367-1370.
|
16 |
Mascia G, Argiolas D, Carta E, et al. Successful treatment of anemia with anaplastic and microangiopathic characteristics in a kidney transplant recipient with parvovirus B19 infection: A case report[J]. Transplant Proc, 2020, 52(5): 1619-1622.
|
17 |
Murdock J, Morris TC, Alexander HD, et al. Red cell aplasia due to erythrovirus parvovirus B19 infection in a Jehovah′s witness with post-transplant EBV-induced aggressive lymphoma: management considerations[J]. Leuk Lymphoma, 2002, 43(1): 211-213.
|
18 |
al-Khaldi N, Watson AR, Harris A, et al. Dual infection with human herpesvirus type 6 and parvovirus B19 in a renal transplant recipient[J]. Pediatr Nephrol, 1994, 8(3): 349-350.
|
19 |
Krishnan P, Ramadas P, Rajendran PP, et al. Effects of parvovirus B19 infection in renal transplant recipients: A retrospective review of three cases[J]. Int J Angiol, 2015, 24(2): 87-92.
|
20 |
Eid AJ, Ardura MI; AST Infectious Diseases Community of Practice, AST Infectious Diseases Community of Practice. Human parvovirus B19 in solid organ transplantation: Guidelines from the American society of transplantation infectious diseases community of practice[J]. Clin Transplant, 2019, 33(9): e13535.
|
21 |
Sharma R, Zachariah M. BK virus nephropathy: Prevalence, impact and management strategies[J]. Int J Nephrol Renovasc Dis, 2020, 13: 187-192.
|
22 |
Sharma R, Tzetzo S, Patel S, et al. BK virus in kidney transplant: Current concepts, recent advances, and future directions[J]. Exp Clin Transplant, 2016, 14(4): 377-384.
|
23 |
Park JB, Kim DJ, Woo SY, et al. Clinical implications of quantitative real time-polymerase chain reaction of parvovirus B19 in kidney transplant recipients - a prospective study[J]. Transpl Int, 2009, 22(4): 455-462.
|
24 |
Carraturo A, Catalani V, Ottaviani D, et al. Parvovirus B19 infection and severe anemia in renal transplant recipients[J]. ScientificWorldJournal, 2012, 2012: 102829.
|
25 |
Inamdar N, Nada R, Minz R, et al. Successful re-transplantation in patient with recurrent parvovirus B19 pure red cell aplasia[J]. Transpl Infect Dis, 2019, 21(6): e13164.
|
26 |
Ardalan MR, Shoja MM, Tubbs RS, et al. Parvovirus B19 microepidemic in renal transplant recipients with thrombotic microangiopathy and allograft vasculitis[J]. Exp Clin Transplant, 2008, 6(2): 137-143.
|
27 |
Eid AJ, Brown RA, Patel R, et al. Parvovirus B19 infection after transplantation: a review of 98 cases[J]. Clin Infect Dis, 2006, 43(1): 40-48.
|
28 |
黄森林,于立新,邓文锋,等. 肾移植术后人类微小病毒B19感染致纯红细胞再生障碍性贫血2例并文献复习[J]. 器官移植,2015, 6(4): 249-253.
|
29 |
Barzon L, Murer L, Pacenti M, et al. Investigation of intrarenal viral infections in kidney transplant recipients unveils an association between parvovirus B19 and chronic allograft injury[J]. J Infect Dis, 2009, 199(3): 372-380.
|
30 |
Means RT Jr. Pure red cell aplasia[J]. Blood, 2016, 128(21): 2504-2509.
|
31 |
Chen XT, Li J, Deng RH, et al. The therapeutic effect of switching from tacrolimus to low-dose cyclosporine A in renal transplant recipients with BK virus nephropathy[J]. Biosci Rep, 2019, 39(2): BSR20182058.
|